Patent · US Active

Methods for detecting Ehrlichia infection

US9151755B2 · kind B2 · utility

1Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 6, 2014
Grant dateOct 6, 2015
Priority date
Expiry dateFeb 6, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides an isolated and purified heat shock protein 60 (Hsp60) peptide having the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to a vaccine against Ehrlichia comprising a peptide homologous to the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to an antibody directed against a peptide homologous to the amino acid sequence of SEQ ID NO:2. The instant invention is also directed to a method of determining whether a subject is infected with Ehrlichia, comprising the steps of: contacting a sample from a subject with the antibody described herein; and detecting a resulting antibody reaction, wherein a positive reaction indicates the subject is infected with Ehrlichia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.